D. J. V. Veldhuisen

The dilemma of the strive for apoptosis in oncology: mind the heart.

E. D. de Vries, J. Gietema, D. V. van Veldhuisen, 2005, Critical reviews in oncology/hematology.

Cardio‐Oncology: Progress in Diagnosis and Treatment of Cardiac Dysfunction

P. van der Meer, J. Tromp, L. Steggink, 2017, Clinical pharmacology and therapeutics.

111Indium-trastuzumab visualises myocardial human epidermal growth factor receptor 2 expression shortly after anthracycline treatment but not during heart failure: a clue to uncover the mechanisms of trastuzumab-related cardiotoxicity.

E. D. de Vries, T. Suter, J. Gietema, 2007, European journal of cancer.

Prospective evaluation of early cardiac damage induced by epirubicin-containing adjuvant chemotherapy and locoregional radiotherapy in breast cancer patients.

M. P. van den Berg, E. D. de Vries, J. Gietema, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Early detection of anthracycline induced cardiotoxicity in asymptomatic patients with normal left ventricular systolic function: autonomic versus echocardiographic variables

H. Crijns, M. P. van den Berg, E. D. de Vries, 1999, Heart.

Different effects of bisoprolol on heart rate in patients with ischemic or idiopathic dilated cardiomyopathy (a 24-hour Holter substudy of the Cardiac Insufficiency Bisoprolol Study [CIBIS]).

H. Crijns, J. Haaksma, J. Brouwer, 1999, The American journal of cardiology.